SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950005-03-000540
Filing Date
2003-05-06
Accepted
2003-05-06 10:05:57
Documents
1
Group Members
ALIX MARDUELALTA BIO PHARMA MANAGEMENT, LLCALTA BIOPHARMA PARTNERS, L.P.ALTA EMBARCADERO BIOPHARMA, LLCALTA PARTNERSALTA/CHASE BIOPHARMA MANAGMENT, LLCDANIEL JANNEYFLAMEL CHASE PARTNERS (ALTA BIO), LLCGARRETT GRUENERGUY NOHRAJEAN DELEAGE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SC13D p17044_sc13da.txt SC 13D/A 54138
  Complete submission text file 0000950005-03-000540.txt   56475
Mailing Address
Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666
FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50223 | Film No.: 03683292
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111 4153624022
ALTA PARTNERS (Filed by) CIK: 0001060013 (see all company filings)

IRS No.: 943238854 | State of Incorp.: CA | Fiscal Year End: 1231